Results of intracoronary stem cell therapy after acute myocardial infarction.
about
Stem cell treatment for acute myocardial infarctionStem cell treatment for acute myocardial infarctionStem cell therapy and tissue engineering for correction of congenital heart diseaseAdult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled TrialsThe stuttering progress of cell therapy for heart diseaseIntracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trialDelivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.Stem cells for cardiac repair in acute myocardial infarction.A multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds.Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective.Clinical trials of cardiac repair with adult bone marrow- derived cells.Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.Stem cells for cardiac repair: status, mechanisms, and new strategies.Cardiac cell therapy: where we've been, where we are, and where we should be headed.Magnetic resonance imaging with superparamagnetic iron oxide fails to track the long-term fate of mesenchymal stem cells transplanted into heart"Second-generation" stem cells for cardiac repairCardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction.Myocardial restoration: is it the cell or the architecture or both?Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis.CMR of microvascular obstruction and hemorrhage in myocardial infarction.Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies.Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction.MRI in acute myocardial infarction.Cell delivery routes for stem cell therapy to the heart: current and future approaches.Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis.Stem cell transplantation in cardiovascular disease: an update.Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review.Cardiospheres and cardiosphere-derived cells as therapeutic agents following myocardial infarction.Use of stem cells in heart failure treatment: where we stand and where we are going.Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials.Value of MR contrast media in image-guided body interventions.The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction.Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction.Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy.Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease.Stem cell transplantation dose in patients with acute myocardial infarction: A meta-analysis.
P2860
Q24186920-4B9DCD99-40B4-44A0-A22A-25314EE4779DQ24203736-D2BD0C79-3A38-45F5-9D54-7D0716A89E74Q26801514-623FC51F-0DBB-479F-8F1E-89C9A58429D7Q28082162-266F18D7-F4DB-4A4C-B8C7-30E4208CDBC2Q28247457-F26F5DD9-F893-4641-9D9F-87CFC49211E4Q29620043-6913A33E-54CE-4E52-B1BA-8D30378D6088Q30473970-7CFDCEDB-6CAA-4D49-8771-55E7813780BCQ30896351-37A3E775-D111-4E19-8B7A-346542F0AEF0Q33352048-7A0D2EB6-A119-4B4A-B059-795B4AD409EFQ33701439-E0178F3B-F5FC-46B6-B79B-8DDD7A71AD7DQ34074673-A26CE778-D1F2-48F8-921D-9E6D389DA4D1Q34306425-C18BACAA-1605-4B50-9E20-6E61DB806B17Q34786321-CECE6EFF-3CEF-4BD7-A0AE-89B225496D14Q34879592-7AF18A46-CB15-44A6-899D-DEE9CB048D4DQ35079018-D5B91700-06EA-41F8-9771-0455C8E4D2D6Q35109987-4843B127-7B28-4E2A-8BE5-EEEDF7ACE7CFQ35144550-E4425BD8-D4A2-4747-A8DB-F13B5ED15AD6Q35169539-03A69DBD-8D81-4899-890F-B3B7D888C1F3Q35205665-C830ECA0-A20F-4CBA-BC34-D6B7F07D8AB7Q35240779-5BC218CA-125B-43C7-AADC-E98714C9942FQ35778889-F7579EF3-4D04-404A-8075-EE47B3561D1AQ36169861-C200C66D-CE37-4ED6-A8EE-39F91F6937ACQ36444582-77650B4C-030B-4C68-81D6-5B40337A58B5Q36807360-A71AE199-218F-47D0-9556-C95EA171BF53Q37016190-2DCD8660-759D-45A9-9A8A-F5BB27B3B02AQ37372331-895180FC-D5D5-4AE7-B3CB-E1A60BC439A0Q37812993-1A34C2EA-8DC5-4BD7-A9CF-25E7F363C624Q38014708-DB910A4C-994F-4E0E-9015-58AD605229CAQ38021450-E5C8F17A-F3FD-41EA-8661-F5CCF084D82FQ38035958-6F244A07-E8A1-44D8-8533-133269C459B5Q38050930-165E6F15-3B60-4E44-8F08-CF1A425E0245Q38055511-75123E1A-34F8-4736-9801-CBC9F6F04335Q38168204-0545EE93-7CC0-4099-B24C-9E99DDDC9069Q38466418-CFD7890E-0CBC-4805-9CD7-5E88115BBE5FQ39653154-7891B4CA-5490-4269-9D45-717C85AA0E83Q42323417-6E94D9E9-EE9B-4061-8F4B-A09FB7825391Q43994483-E483907C-A361-4580-B5B1-163D03F4EF7DQ47338535-52941B86-1718-486F-8336-06EC49BDDF3EQ49288386-0ECAC169-FCFB-4942-927E-B25E54F2464BQ55087466-9067501E-7C9F-455D-B892-5918571A8A68
P2860
Results of intracoronary stem cell therapy after acute myocardial infarction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Results of intracoronary stem cell therapy after acute myocardial infarction.
@ast
Results of intracoronary stem cell therapy after acute myocardial infarction.
@en
Results of intracoronary stem cell therapy after acute myocardial infarction.
@nl
type
label
Results of intracoronary stem cell therapy after acute myocardial infarction.
@ast
Results of intracoronary stem cell therapy after acute myocardial infarction.
@en
Results of intracoronary stem cell therapy after acute myocardial infarction.
@nl
prefLabel
Results of intracoronary stem cell therapy after acute myocardial infarction.
@ast
Results of intracoronary stem cell therapy after acute myocardial infarction.
@en
Results of intracoronary stem cell therapy after acute myocardial infarction.
@nl
P2093
P1476
Results of intracoronary stem cell therapy after acute myocardial infarction.
@en
P2093
Fabian von Scheidt
Hubert Schrezenmeier
Jochen Wöhrle
Klaus Schwarz
Markus Wiesneth
Martin Bommer
Nico Merkle
Peter Schauwecker
Thorsten Nusser
Vinzenz Hombach
P304
P356
10.1016/J.AMJCARD.2009.10.060
P407
P577
2010-03-01T00:00:00Z